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Abstract Adipose-derived stem cells (ASCs) are promis-
ing candidates for therapy in myocardial infarction (MI).
However, the frequency of human ASCs that differentiate
towards cardiomyocytes is low. We hypothesized that
adherence to extracellular matrix molecules that are
upregulated after MI might increase human stem cell
differentiation towards cardiomyocytes. We analysed puta-
tive ASC differentiation on fibronectin-coated, laminin-
coated and uncoated culture plates. Expression of cardiac
markers in cells was analysed 1, 3 and 5 weeks after
stimulation with 5-aza-2-deoxycytidine. After 1 week,
mRNA expression of myosin light chain-2α (MLC-2α),
an early marker in cardiomyocyte development, was
increased significantly in treated cells, independent of
coating. At 5 weeks, however, mRNA expression of the late
cardiomyocyte development marker SERCA2α was only
significantly increased in 5-aza-2-deoxycytidine-treated
cells cultured on laminin. Significantly higher numbers of
cells were immunopositive for MLC-2α in cultures of
treated cells grown on laminin-coated wells, when compared
with cultures of treated cells grown on uncoated wells, both
at 1 week and at 5 weeks. Furthermore, after 3 weeks,
significantly more α-actinin- and desmin-positive cells were
detected after treatment with 5-aza-2-deoxycytidine, but
only in uncoated wells. After 5 weeks, however, the number
of desmin-positive cells was only significantly increased
after treatment of cells with 5-aza-2-deoxycytidine and
culture on laminin (61% positive cells). Thus, we have
found that a high percentage of human ASCs can be
differentiated towards cardiomyocytes; this effect can be
improved by laminin, especially during late differentiation.
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Introduction
Cardiovascular diseases are a leading cause of morbidity
and mortality in the western world (Wang and Sjoquist
2006), with heart failure resulting from myocardial infarc-
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tion (MI) being the most common aetiology (Lu et al. 2004).
Heart failure is partly caused by the loss of cardiomyocytes
and the limited capacity of spontaneous regeneration of the
heart. This results in replacement of injured myocardium by
scar tissue, which adversely affects cardiac function (Smits
et al. 2005; Wang and Sjoquist 2006).
A promising tool for the restoration of contractile
function after MI is stem cell therapy. In comparison with
current therapies that focus on the restoration of the blood
flow, stem cells not only might improve neovascularization,
but also might replace lost cardiomyocytes, since they have the
capacity to differentiate into cardiomyocytes (Wang and
Sjoquist 2006; Orlic et al. 2001; Strauer et al. 2002). However,
effectively to restore contractile function of the heart after MI,
sufficient stem cells need to attach to the infarcted area and
subsequently differentiate into cardiomyocytes, thereby
replacing a substantial fraction of the lost cardiomyocytes.
Unfortunately, recent studies suggest that only a small portion
of stem cells applied to the heart invade the infarcted area and
ultimately differentiate into cardiomyocytes (Lee et al. 2007).
Several factors might influence the fate of the stem cells
in the heart. One of these is the source of stem cells used.
Although various cell sources have been used experimen-
tally for stem cell transplantation after MI, the optimal
choice of stem cell source remains controversial (Zhang et
al. 2007). A potential source of stem cells for transplanta-
tion is adipose tissue. Adipose-tissue-derived stem cells
(ASCs) are of mesenchymal origin, can easily be harvested
in large quantities, show high proliferation rates in culture
and have the capacity to differentiate towards several cell
types, including cardiomyocytes (Rangappa et al. 2003;
Oedayrajsingh-Varma et al. 2006).
Several studies have shown the differentiation of animal
ASCs towards cardiomyocytes after treatment with chem-
ical substances such as 5-azacytidin. Spontaneous differen-
tiation of ASCs towards cardiomyocytes has also been
described (Planat-Benard et al. 2004; Rangappa et al. 2003;
Bai et al. 2007). Furthermore, in vivo animal studies, in
which ASCs have been transplanted after MI, have also
shown the differentiation of ASCs towards cardiomyocytes
and increased cardiac function (Strem et al. 2005; Zhang
et al. 2007). However, studies on human ASCs are limited,
and only low percentages (<2%) of spontaneous differen-
tiation have been described (Bai et al. 2007; Song et al.
2007). Only Gaustad et al. (2004) have described a higher
differentiation rate (25% desmin-positive cells) of human
ASCs in vitro, but only in one donor and only after the cells
had been permeabilized and exposed to extracts of rat
cardiomyocytes. Before the translation of human ASCs to a
clinical setting, we therefore need to show that a significant
number of such cells can differentiate into cardiomyocytes.
Another important factor for stem cell adherence and
differentiation is the timepoint of transplantation after MI
(Lu et al. 2004). Homing, growth and differentiation of
stem cells after MI is known to depend on the environment
in the heart, and especially on the adhesion factors at the
site of injury, all of which change dramatically after MI (Lu
et al. 2004; Malek et al. 2006; Wang and Sjoquist 2006;
Chastain et al. 2006; Salasznyk et al. 2004). Therefore,
stem cell therapy has to be applied at the moment after
infarction when the environment is most favourable for
stem cell adhesion and cardiomyocyte formation. Two
extracellular matrix (ECM) molecules of human mesenchy-
mal stem cells are important for stem cell survival and
differentiation towards other lineages: laminin and fibro-
nectin (Hashimoto et al. 2006; Salasznyk et al. 2004;
Wijelath et al. 2004). Both these proteins are expressed in
the normal heart and increase after MI (Froen and Larsen
1995; Knowlton et al. 1992; Willems et al. 1996). In vivo,
an effect of these ECM molecules on stem cell survival and
differentiation can be expected if stem cell therapy is
applied once these proteins have accumulated. In a previous
study, we have shown that ASCs attach best to fibronectin
in comparison with other ECM molecules; we have also
demonstrated that fibronectin is increased from 12 h
onwards after MI in the human heart (van Dijk et al.
2008). Further, laminin is described to increase from 3 days
post-MI (Morishita et al. 1996).
Our ultimate goal is to optimize stem cell transplantation
by directing a larger number of stem cells to the infarction
site and by stimulating stem cell differentiation in vivo. In
this study, we have therefore investigated the effect of
fibronectin and laminin on the putative differentiation of
human ASCs towards cardiomyocytes.
Materials and methods
Adipose tissue donors
Human subcutaneous adipose tissue samples were obtained
as waste material after elective surgery and donated after
informed consent of the patients from various clinics in
Amsterdam, The Netherlands. This study complied with the
principles of the Declaration of Helsinki. Adipose tissue
was harvested from the abdomen or hip and thigh region by
using either resection or tumescent liposuction. Seven
healthy non-obese female donors (age range: 33–51 years)
were included in this study.
Isolation of stromal vascular fraction of adipose tissue
Adipose tissue was stored in sterile phosphate-buffered
saline (PBS; Braun, Melsungen, USA) at 4°C and pro-
cessed within 24 h after surgery as described previously
(Oedayrajsingh-Varma et al. 2006). In brief, resected
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material was minced by using a surgical scalpel before
being processed. After extensive washes with PBS, the
ECM was enzymatically digested with 0.1% collagenase A
(Roche Diagnostics, Mannheim, Germany) in PBS contain-
ing 1% bovine serum albumin (BSA; Roche Diagnostics)
under intermittent shaking for 45 min at 37°C. Then, the
material was washed with Dulbecco’s modified Eagle’s
medium (DMEM-glucose; BioWhittaker, Cambrex, Verviers,
Belgium) containing 10% fetal bovine serum (FBS;
HyClone, South Logan, Utah, USA) and centrifuged for
10 min at 600g. The cell pellet was resuspended in PBS
and passed through a 200-μm mesh (Braun/Beldico,
Marche-en-Famenne, Belgium) to obtain a single-cell
suspension. To remove contaminating erythrocytes, the
cells were subjected to Ficoll density centrifugation
(lymphoprep, ρ=1.077 g/ml, osmolarity 280±15 mOsm;
Axis-Shield, Oslo, Norway). The cell-containing interface
was harvested and washed with DMEM containing 10%
FBS. Cells were frozen under “controlled rate” conditions
and stored in liquid nitrogen until needed in experiments.
Cell culture
Cells from the stromal vascular fraction were seeded at
1×105 cells/cm2 and cultured for several passages in
DMEM supplemented with 10% FBS, 100 U/ml penicillin,
100 µg/ml streptomycin, 2 mM L-glutamine (all from
Gibco, Invitrogen, Calif., USA; normal culture medium), in
a humidified atmosphere of 5% CO2 at 37°C. Media were
changed twice a week. Once 80%–90% confluency has
been reached, cells were detached with 0.5 mM EDTA/
0.05% trypsin (Gibco), for 5 min at 37°C, and replated.
To assess ASC differentiation towards cardiomyocytes,
culture-expanded cells (p3) were plated into 6-well culture
dishes at a density of 50,000 cells per well, each well
having been coated with 2.5 μg/cm fibronectin (Roche) or
0.12 μg/cm laminin (Roche) or left uncoated, in normal
culture medium. The cells were then cultured in DMEM
containing 15% FBS and, when 50–60% confluent,
stimulated with 5-aza-2-deoxycytidine (9 μM; Fluka,
Sigma Aldrich, St. Louis, Mo. USA) for 24 h in DMEM
supplemented with 15% FBS, 100 U/ml penicillin, 100 µg/ml
streptomycin, 2 mM L-glutamine and 1% ITS + premix
(BD Biosciences, Bedford, Mass., USA). This concentra-
tion of 5-aza-deoxycytidine has been shown to induce
differentiation of rabbit ASCs towards cardiomyocytes on
uncoated culture plates (Rangappa et al. 2003). Cells were
harvested after 1, 3 and 5 weeks.
Reverse transcription with polymerase chain reaction
Cells were harvested in 750 μl TRIzol reagent (Invitrogen)
per well (10 min, room temperature), after 1 and 5 weeks.
Total RNA from the cells was isolated by incubating the
samples in 150 μl chloroform for 2 min after vigourous
shaking. Samples were centrifuged for 15 min at 12,000g
and the upper water phase was transferred to a new tube
containing 5 μl glycogen (1 μg/μl) and 375 μl isopropyl.
After a 10-min incubation at room temperature, the cells
were centrifuged for 10 min at 12,000g and the pellet was
washed with 1 ml 75% ethanol. The samples were
centrifuged again for 5 min at 7500g and, when the RNA-
pellet was dried, it was taken up in RNAse-free water.
cDNA synthesis (GeneAmp PCR System9700, PE
Applied Biosystems, Calif., USA) was performed by using
0.5–1 mg total RNA in a 20-ml reaction mix containing 5 U
Transcriptor Reverse Transcriptase (Roche), 0.08 A260 U
random primers (Roche), 1 mM each dNTP (Invitrogen),
RNAse inhibitor, and 1× concentrated Transcriptor reverse
transcription (RT) reaction buffer. The cDNA was stored at
−80°C prior to real-time polymerase chain reaction (PCR).
Real-time PCRs were performed by using the SYBR-
Green reaction kit according to the manufacturer’s instruc-
tions (Roche) in a LightCycler 480 (Roche). cDNA (∼5 ng)
was used in a volume of 20 µl PCR mix (LightCycler DNA
Master Fast start plus Kit, Roche) containing a final
concentration of 0.5 pmol primers. Relative housekeeping
gene expression (18S) and relative target gene expression
(cardiac-specific SERCA2α, myosin light chain-2α [MLC-
2α], desmin and α-actinin) were determined.
Primers (Invitrogen) used for real-time PCR are listed in
Table 1. They were designed by using Clone Manager Suite
software program version 6 (Scientific & Educational
Software, Cary, N.C., USA). The amplified PCR fragment
extended over at least one exon border, based on homology
in conserved domains between human, mouse, rat, dog and
cow, except for the 18S gene, which is encoded by one
exon only.
PCR conditions were as follows: for 18S, a 1-min pre-
incubation at 95°C, followed by 30 cycles of amplification
at 95°C for 5 s, 56°C for 10 s, 72°C for 15 s, and 82°C for
5 s, followed by melting curve analysis; for MLC-2α,
SERCA, desmin and α-actinin, a 10-min pre-incubation at
95°C, followed by 45 cycles of amplification at 95°C for
5 s, 58°C for 5 s, 72°C for 15 s, and 82°C for 5 s followed
by melting curve analysis.
Quantification was carried out by normalizing the values
of relative target gene expression to relative housekeeping
gene (18S) expression. Amplified PCR products were electro-
phoresed on a 1.6% agarose gel containing 0.5 μg/ml
ethidium bromide.
Immunological staining
Cells were trypsinized after 3 and 5 weeks. Cytospin slides
were prepared by spinning 104 ASCs for 5 min at 500 rpm
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(Shandon cytospin 3, Thermo Scientific, Waltham, Mass.,
USA). Slides were air-dried overnight, fixed with acetone
for 10 min, incubated with mouse antibodies against human
desmin (1:75, Sigma), α-actinin (1:300, Sigma), troponin
T (1:75, AbD Serotec, Oxford, UK) or MLC-2α (1:100,
Synaptic Systems, Göttingen, Germany) in PBS containing
1% BSA (PBS/BSA) for 1.5 h at room temperature, washed
with PBS, and incubated with biotin-conjugated rabbit-anti-
mouse antibodies (1:300, Dako Cytomation, Glostrup,
Denmark) for 30 min. After being washed in PBS, the
slides were incubated with streptavidin-biotin complex/
horseradish peroxidase (sABC/HRP; 1:200, Dako) for 1 h.
Staining was visualized by using 3-amino-9-ethylcarbazole
(AEC; Zymed AEC kit, Invitrogen). Finally, the cells were
counterstained with hematoxylin and covered. Control
slides were incubated with PBS instead of the primary
antibody and showed no positive staining. All cytospin
slides were scored blindly for the percentage of AEC
positive cells; 100 cells were scored per slide.
Statistics
Statistics were performed with the SPSS statistics program
(windows version 9.0) and Graphpad Prism (version 4).
The Repeated Measures method was used if values were
obtained for all samples. Otherwise, an analysis of variance
(ANOVA) was used if scores were distributed normally; if
not or if n was too small, a Kruskall-Wallis test was used
for analysis. A P-value smaller than 0.05 was considered to
be statistically significant. Values are given as mean ± SE.
Results
To investigate the effect of ECM proteins on cardiomyocyte
differentiation, ASCs were cultured in fibronectin- or
laminin-coated wells or in uncoated wells, with or without
treatment with 5-aza-2-deoxycytidine. Before stimulation,
ASCs displayed a fibroblast morphology, as previously
described (Fig. 1a; Rangappa et al. 2003; Gaustad et al.
2004). After stimulation, the morphology of the cells
changed. At 2 weeks, cells became larger and more
elongated. Further, we found smaller numbers of ASCs in
the wells that were treated with5-aza-2-deoxycitidine,
suggesting a reduction of proliferation capacity (not
shown). From 3 weeks after stimulation, multinucleated
cells and ball-like figures were present in the wells
containing 5-aza-2-deoxycitidine-stimulated cells, especial-
Fig. 1 Morphology of cells
after treatment with 5-aza-2-
deoxycytidine. a Untreated cells
on uncoated culture wells. ASCs
display fibroblast morphology. b
Cells treated with 5-aza-2-
deoxycytidine are elongated
(arrow I) or occur in ball-like
figures (arrow II). Note the low
cell number
Table 1 PCR primers and PCR conditions
Gene Primer Annealing Size
Temp (°C) (basepair)
18S F 5′ GTAACCCGTTGAACCCCATT- 3′ 56 151
R 5′ CCATCCAATCGGTAGTAGCG 3′
MLC-2α F 5′-ATC TGC AAG GCA GAC CTG A-3′ 55 243
R 5′-CAG GAG AAG CTG CTT GAA C-3′
SERCA-2α F 5′-TCT GGC ACT GCG GTG GCT AA-3′ 55 241
R 5′-GGC CAT CTG TCA CCA GAT T-3′
Desmin F 5′-TGTGGAGATTGCCACCTAC-3′ 64 185
R 5′-CGTGTCTCGATGGTCTTGAT-3′
Actinin F 5′-CCATGCTGCGACAGAAGGA-3′ 64 337
R 5′-CCCTCCATCCAGTTGTTGA-3′
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ly in the laminin-coated wells (Fig. 1b). mRNA expression
of cardiac markers was studied by using RT-PCR. The
control consisted of cells that were cultured on uncoated
culture wells and not treated with 5-aza-2-deoxycitidine. In
untreated cells, we could not detect any differences in
SERCA-2α and MLC-2α mRNA expression between
uncoated wells and wells coated with fibronectin or
laminin, both after 1 and 5 weeks of culture (not shown).
However, 1 week after treatment with 5-aza-2-deoxyciti-
dine, mRNA expression of the early cardiac marker MLC-
2α (Kubalak et al. 1994) was increased over 10-fold when
compared with untreated cells (Fig. 2a, n=7, P<0.05). This
increase, however, was independent of coating. At 5 weeks
after treatment, the expression of MLC-2α mRNA was no
longer found to be significantly increased when compared
with untreated cells. mRNA expression for α-actinin was
not significantly different between the different timepoints
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Fig. 2 Relative mRNA expres-
sion of cardiac markers in ASCs
grown on uncoated culture wells
(−) or on wells coated with
laminin (lam) or fibronectin (fib)
and either untreated (−) or
treated (+) with 5-aza-2-
deoxycytidine. Results are
compared with untreated cells
cultured on uncoated culture
wells (error bars SEM).
a Relative mRNA expression of
myosin light chain-2α (MLC-
2α; n=7, *P<0.05, **P<0.01;
Repeated Measures). b Relative
mRNA expression of α-actinin
(n=5). c Relative mRNA
expression of desmin (n=5).
d Relative mRNA expression of
SERCA-2α (n=7, *P<0.05,
Repeated Measures)
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1 and 3 weeks, independent of coating. However, a clear
trend was visible showing an increased expression of
desmin mRNA expression at 5 weeks in stimulated cells,
especially in the cells in coated culture wells (Fig. 2c, P=
0.10 for laminin and fibronectin, compared with untreated
cells after 5 weeks, n=5).
mRNA expression of the late differentiation marker
cardiac SERCA2α (Fijnvandraat et al. 2003) was not found
to be significantly increased at 1 week after treatment with
5-aza-2-deoxycytidine. After 5 weeks, however, a signifi-
cant increase of SERCA-2α expression was found in
treated cells that were cultured on laminin (Fig. 2d, n=7,
P<0.05). This increase was not found when cells were
cultured in uncoated culture wells or on fibronectin.
To exclude that stimulation with 5-aza-2-deoxycitidine
also triggered the differentiation of ASC towards other
lineages, we also tested our samples for markers for
osteogenic and chondrogenic lineages at 5 weeks after
treatment, as described previously (Jurgens et al. 2008). No
expression of the chondrogenic marker collagen type 2b
was found in any of the samples. Some expression of the
chondrogenic marker aggrecan was found; however, this
amount was too low to quantify. A low expression of the
osteogenic markers osteopontin and collagen type 1A were
found but no differences were found between untreated and
treated cells suggesting that we had not induced differen-
tiation into lineages other than the cardiac lineage by using
5-aza-2-deoxycitidine (not shown).
These results suggested that fibronectin and laminin had
no additional affect on mRNA expression of cardiac
markers during early differentiation, whereas the adherence
of ASCs to laminin significantly improved late differenti-
ation towards cardiomyocytes.
To exclude a putative effect of a lower concentration of
fibronectin on differentiation, we also tested fibronectin at a
single dose of 0.12 μg/cm. This did not induce cardiac
differentiation (not shown).
After studying mRNA expression, we next examined the
protein expression of the cardiac markers MLC-2α, α-
actinin, desmin and troponin T at 1, 3 and 5 weeks after
treatment. No protein expression could be detected for α-
actinin, desmin and troponin in cells at 1 week after
treatment (not shown). Notably, when cells were not treated,
no differences in the numbers of desmin- and actinin-
positive cells were found between uncoated wells and wells
coated with fibronectin or laminin (not shown). In Fig. 3,
representative examples of immunocytochemical staining
of these proteins in cells derived from the same donor are
shown; a considerable number of cells stained positively for
α-actinin, desmin, troponin T and MLC-2α only in wells
containing cells treated with 5-aza-2-deoxycytidine.
We next quantified the immunocytochemical staining.
We found that, at 1 week after treatment with 5-aza-2-
deoxycitidine, significantly more cells were positive for
MLC-2α, when compared with untreated cells, but only in
the wells containing treated cells cultured on laminin
(Fig. 4a; 20±4% in untreated cells versus 51±9% in
laminin-coated wells, P<0.01). The percentage of MLC-
2α-positive cells on the laminin-coated wells was also
significantly higher when compared with the 5-aza-2-
deoxycitidine-treated cells on uncoated culture wells (un-
coated 26±7% versus laminin 51±9%, P<0.05). After
3 weeks, no differences were found between the treated
cells on the laminin-coated culture wells and on the
uncoated culture wells. However, the percentage of MLC-
2α-positive cells was significantly lower in treated cells on
fibronectin-coated culture wells than on uncoated culture
wells (uncoated 52±2% versus 27±2%, P<0.01). After
5 weeks, again only the wells coated with laminin
contained a significantly higher number of MLC-2α-
positive cells, when compared with untreated cells (untreat-
ed 30±4% versus laminin 46±7%, P<0.05). These results
suggest a positive effect of laminin coating on MLC-2α
expression in ASCs.
We further found that, at 3 weeks after treatment,
cytospin slides showed an increased number of treated
cells staining positively for the intermediate marker α-
actinin when compared with untreated cells (Fig. 4b).
However, this number was only significantly increased
when ASCs were cultured in uncoated wells (67±12%
versus 5±2%, P<0.05). Percentages of positive cells on
fibronectin- and laminin-coated culture wells were, respec-
tively, 21±8% and 28±11% (P=0.16 and P=0.20, respec-
tively, compared with untreated). After 5 weeks, however,
the percentage of α-actinin positive cells in the uncoated
culture wells was no longer significantly increased when
compared with untreated cells and was similar to the
percentage of positive cells in the wells coated with laminin
and fibronectin (uncoated: 29±20%, laminin-coated: 28±
13%, fibronectin-coated: 26±10%).
Moreover, an increased number of desmin-positive cells
(late marker) was found at 3 weeks after treatment (Fig. 4c).
However, once again, this increase was only significant
when cells were cultured in uncoated wells (74±12%
versus 5±1%, P<0.05). Percentage of positive cells in
fibronectin- and laminin-coated culture wells were, respec-
tively, 44±15% and 42±16% (P=0.11 and P=0.16,
respectively). By 5 weeks after treatment, the percentage
of desmin-positive cells cultured on uncoated and fibronectin-
coated culture wells decreased, but not significantly, when
compared with that at 3 weeks (fibronectin-coated: 44±15%
to 9±7%, P=0.07; uncoated: 74±12% to 34±17%, P=
0.17). In contrast, when cells were cultured on laminin, the
number of desmin-positive cells increased, but not signifi-
cantly, compared with that at 3 weeks. More importantly, in
these laminin-coated culture wells, the number of desmin-
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positive cells was significantly increased compared with
untreated cells (61±12% versus 3±1%, P<0.05).
Finally, we also quantified troponin T protein expression
(Fig. 4d, n=3). We found that, after 3 and 5 weeks, the
percentage of positive cells was low in untreated cells (2%
and 1%, respectively). In contrast, all wells containing
treated cells showed higher numbers (17%–32%) of
troponin-T-positive cells, independent of coating; the
highest percentages of positive cells were found in the
uncoated wells at 3 and 5 weeks and in the laminin-coated
culture wells at 3 weeks. These findings, however, were not
statistically significant.
Thus, at the protein level, differentiation towards cardio-
myocytes was also only found to be significantly increased in
cells treated with 5-aza-2-deoxycytidine and cultured on
laminin, especially with regard to late differentiation.
Discussion
We hypothesized that the attachment of ASCs to ECM
molecules that are normally present in the healthy heart and
that become upregulated after infarction would increase
stem cell differentiation towards cardiomyocytes. There-
fore, we have studied the effect of laminin and fibronectin
on the differentiation of ASCs in vitro. We have found that
a high percentage of human ASCs can differentiate towards
cardiomyocytes, as shown at the mRNA level (MLC-2α,
Fig. 3 Immunocytochemical
analysis of the expression (red)
of α-actinin (a–c, 3 weeks),
desmin (d–f, 5 weeks), Troponin
T (g–i, 3 weeks) and MLC-2a
(j–l, 5 weeks) in cells with and
without treatment with 5-aza-
2-deoxycitidine. a, d, g, j
Untreated cells on uncoated
culture wells (arrow I nuclei
counterstained blue). b, e, h, k
Treated cells on uncoated
culture wells (arrow II positive
red staining for α-actinin). c, f,
i, l Treated cells cultured on
laminin-coated culture wells
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SERCA) and at the protein level (MLC-2α,α-actinin, desmin,
troponin T), and that the ECM molecule laminin, but not
fibronectin, plays a role in the differentiation of ASCs towards
cardiomyocytes, especially during late differentiation.
Although some studies have previously described the
differentiation of human ASCs towards cardiomyocytes
(Bai et al. 2007; Song et al. 2007), this is the first time, to
the best of our knowledge, that such a large number of
human ASCs has been shown to differentiate along this
route. Notably, we have demonstrated this effect in cells
derived from several donors. Only Gaustad et al. (2004)
have described the differentiation of human ASCs at levels
comparable with ours; however they only studied ASCs
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Fig. 4 Number of ASCs
showing protein expression for
cardiac markers after growth on
uncoated culture wells (−) or on
wells coated with laminin (lam)
or fibronectin (fib) and either
untreated (−) or treated (+) with
5-aza-2-deoxycytidine. Results
are expressed as percentage of
positive cells and are compared
with untreated cells (error bars
SEM). a Myosin light chain-2α
(MLC-2α) expression in ASCs
(n=5, *P<0.05, **P<0.01,
ANOVA). b α-Actinin expres-
sion in ASCs (n=7, *P<0.05,
Repeated Measures). c Desmin
expression in ASCs (n=7,
*P<0.05, **P<0.01, Repeated
Measures). d Troponin T
expression in ASCs (n=3,
Repeated Measures)
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after stimulation and grown on uncoated culture plates are
similar to the data of Gaustad et al. (2004) who have shown
α-actinin expression in 81% (our study 67%) and desmin
expression in 25% (our study 74%) of their cells.
Furthermore, we have found an additional effect of
culturing the cells on laminin, since the percentage of
desmin-positive cells in uncoated culture wells decreased
again after 5 weeks (35%), whereas the percentage of
desmin-positive cells in laminin-coated culture wells
increased up to 61%.
A major difference from the study of Gaustad et al.
(2004) is that they permeabilized their ASCs and subjected
them to rat cardiomyocyt extracts to achieve cardiomyocyte
differentiation. Instead, we have used 2-deoxy-5-azacytidin,
a demethylating agent that can be employed to prime cells
before transplantation in vivo (Zhang et al. 2007; Burlacu
2006) and that is thus possibly more suitable for clinical
use. Such a priming of stem cells in vitro before
transplantation might be important, since theoretically this
would prevent the spontaneous differentiation of stem cells
into undesired lineages (Heng et al. 2004).
The positive effect of laminin on late stem cell
differentiation might be caused by a real increase of
differentiation attributable to laminin, although we cannot
exclude that the attachment to laminin prevents the cells
from dedifferentiation because, in the uncoated culture
wells, both the percentages of α-actinin- and desmin-
positive cells decreases between 3 and 5 weeks after
treatment. However, since an increase of desmin-positive
cells occurs, albeit not significantly, between 3 and 5 weeks
in the laminin-coated culture wells, the positive effect of
laminin is probably caused not only by the prevention of
dedifferentiation, but also by a real increase in the number
of cells that have differentiated during this period.
Although previous studies have suggested that the
presence of the ECM that is normally present in the heart
plays an important role in stem cell differentiation towards
cardiomyocytes (Baharvand et al. 2005), this is, to the best
of our knowledge, the first time that a positive effect of
laminin attachment on stem cell differentiation towards
cardiomyocytes has been described. Laminins are hetero-
trimers of large polypeptides (Kuang et al. 1998). In
contrast to many matrix components that are ubiquitous in
their distribution in the developing embryo, laminin is
localized only in the basement membranes (Foster et al.
1987). This restricted distribution of laminin suggests a
specific role for laminin in cell attachment, spreading and
differentiation in embryogenesis. Indeed, laminin has been
described to attach to myocardial cells as the principle
adhesive molecule for the maintenance of architecture and
differentiation in the embryo (Kim et al. 1999).
Several studies have described an effect of laminin on
myogenesis. For example, Foster et al. (1987) have found
that a laminin substrate promotes myogenesis in rat skeletal
muscle cultures and Hilenski et al. (1992) have reported
that laminin influences cytoskeletal and myofibrillar orga-
nization in vitro in neonatal rat cardiac myocytes. Further,
mutations in the genes coding for the alpha-2 chain of two
laminin isoforms have been shown to cause a severe form
of congenital muscular dystrophy in humans and mice
(Kuang et al. 1998).
Thus, laminin is known to play a role in regulating the
differentiated phenotype of cells. Further, a large number of
integrins have been described to interact with laminins
(Thorsteinsdottir et al. 1999). In addition to their ability to
link cells to their extracellular environment, integrins
possess cytoplasmic domains that function in cellular
signalling via their ability to associate with and activate
signal transduction pathways (Kuang et al. 1998; Belkin and
Stepp 2000). The interaction between integrins and laminins
therefore can lead to many developmentally relevant
processes, such as cell differentiation (Thorsteinsdottir et al.
1999).
In this study, we have found an effect of laminin on ASC
differentiation, but no significant effect has been seen for
fibronectin on ASC differentiation towards cardiomyocytes.
However, we have previously reported that fibronectin
improves stem cell attachment and proliferation (van Dijk
et al. 2008). Other studies have also described the positive
effect of laminin and the negative effect of fibronectin on
myoblast formation. For example, Vachon et al. (1996)
suggest that laminin plays a role in myoblast adhesion and
myotube formation, whereas fibronectin stimulates myoblast
adhesion and proliferation but does not improve myogenic
differentiation. Moreover, Thyberg and Hultgardh-Nilsson
(1994) have shown that laminin retains freshly isolated rat
aortic smooth muscle cells in a contractile phenotype in
primary culture, whereas fibronectin does not have this
effect.
In previous studies, we have demonstrated that fibro-
nectin stimulates ASC attachment and now we have shown
that laminin promotes ASC differentiation. Since both
laminin and fibronectin are upregulated after MI, their
described effects might thus enhance ASC differentiation
towards cardiomyocytes for MI therapy by stem cells. We
therefore suggest that stem cell therapy should be applied
when both fibronectin deposition (12 h to 15 days after MI,
unpublished data) and laminin deposition (from day 3 after
MI; Morishita et al. 1996) are high, i.e. from 3 days after
MI.
Several other studies have also investigated the best
timeframe after MI for the application of stem cell therapy,
both in animal models and with regard to human stem cell
transplantation, by examining molecular events and stem
cell retention at the site of infarction (Lu et al. 2004; Ma et
al. 2005; Bermejo et al. 2006). These investigations suggest
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that stem cell therapy should be applied neither during the
acute inflammation phase (within 1 day after infarction),
nor after a period longer than 2 weeks when scar tissue has
formed. This is in agreement with our suggestion that stem
cell therapy should be applied at least 3 days after MI.
In summmary, we have shown, for the first time, that a
high percentage of human ASCs can differentiate towards
cardiomyocytes and that the attachment of these cells to
laminin improves late ASC differentiation towards cardio-
myocytes. To achieve a positive effect of the ECM
molecules fibronectin and laminin on the retrieval and
differentiation of stem cells for use in the heart after MI,
stem cell therapy should be applied when the deposition of
these ECM molecules is high in the heart, i.e. at least
3 days after MI.
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Creative Commons Attribution Noncommercial License which per-
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medium, provided the original author(s) and source are credited.
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